Gel-Dispersed Nanostructures Lipid Carriers Loading Thymol Designed for Dermal Pathologies
<p><strong style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">Purpose:</strong><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> </span><em style="background-color:rgb( 255 , 255 , 255 );c...
| Autores: | , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2024 |
| País: | España |
| Institución: | Universidad de Barcelona |
| Repositorio: | Dipòsit Digital de la UB |
| OAI Identifier: | oai:diposit.ub.edu:2445/207864 |
| Acceso en línea: | https://hdl.handle.net/2445/207864 |
| Access Level: | acceso abierto |
| Palabra clave: | Gels (Farmàcia) Emulsions (Farmàcia) Nanopartícules Gels (Pharmacy) Emulsions (Pharmacy) Nanoparticles |
| id |
ES_084f52a35eb05ffccdb27d854b4342aa |
|---|---|
| oai_identifier_str |
oai:diposit.ub.edu:2445/207864 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Gel-Dispersed Nanostructures Lipid Carriers Loading Thymol Designed for Dermal Pathologies |
| title |
Gel-Dispersed Nanostructures Lipid Carriers Loading Thymol Designed for Dermal Pathologies |
| spellingShingle |
Gel-Dispersed Nanostructures Lipid Carriers Loading Thymol Designed for Dermal Pathologies Carvajal Vidal, Paulina Andrea Gels (Farmàcia) Emulsions (Farmàcia) Nanopartícules Gels (Pharmacy) Emulsions (Pharmacy) Nanoparticles |
| title_short |
Gel-Dispersed Nanostructures Lipid Carriers Loading Thymol Designed for Dermal Pathologies |
| title_full |
Gel-Dispersed Nanostructures Lipid Carriers Loading Thymol Designed for Dermal Pathologies |
| title_fullStr |
Gel-Dispersed Nanostructures Lipid Carriers Loading Thymol Designed for Dermal Pathologies |
| title_full_unstemmed |
Gel-Dispersed Nanostructures Lipid Carriers Loading Thymol Designed for Dermal Pathologies |
| title_sort |
Gel-Dispersed Nanostructures Lipid Carriers Loading Thymol Designed for Dermal Pathologies |
| dc.creator.none.fl_str_mv |
Carvajal Vidal, Paulina Andrea Folle, Camila Marqués Villavecchia, Ana M. Díaz-Garrido, Natalia Sánchez-López, E. (Elena) Suñer Carbó, J. (Joaquim) Halbaut, Lyda Mallandrich Miret, Mireia Espina García, Marta Badía Palacín, Josefa Baldomà Llavinés, Laura García López, María Luisa Calpena Campmany, Ana Cristina |
| author |
Carvajal Vidal, Paulina Andrea |
| author_facet |
Carvajal Vidal, Paulina Andrea Folle, Camila Marqués Villavecchia, Ana M. Díaz-Garrido, Natalia Sánchez-López, E. (Elena) Suñer Carbó, J. (Joaquim) Halbaut, Lyda Mallandrich Miret, Mireia Espina García, Marta Badía Palacín, Josefa Baldomà Llavinés, Laura García López, María Luisa Calpena Campmany, Ana Cristina |
| author_role |
author |
| author2 |
Folle, Camila Marqués Villavecchia, Ana M. Díaz-Garrido, Natalia Sánchez-López, E. (Elena) Suñer Carbó, J. (Joaquim) Halbaut, Lyda Mallandrich Miret, Mireia Espina García, Marta Badía Palacín, Josefa Baldomà Llavinés, Laura García López, María Luisa Calpena Campmany, Ana Cristina |
| author2_role |
author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Gels (Farmàcia) Emulsions (Farmàcia) Nanopartícules Gels (Pharmacy) Emulsions (Pharmacy) Nanoparticles |
| topic |
Gels (Farmàcia) Emulsions (Farmàcia) Nanopartícules Gels (Pharmacy) Emulsions (Pharmacy) Nanoparticles |
| description |
<p><strong style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">Purpose:</strong><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> </span><em style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">Acne vulgaris</em><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> is one of the most prevalent dermal disorders affecting skin health and appearance. To date, there is no effective cure for this pathology, and the majority of marketed formulations eliminate both healthy and pathological microbiota. Therefore, hereby we propose the encapsulation of an antimicrobial natural compound (thymol) loaded into lipid nanostructured systems to be topically used against acne.</span><strong style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">Methods:</strong><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> To address this issue, nanostructured lipid carriers (NLC) capable of encapsulating thymol, a natural compound used for the treatment of acne vulgaris, were developed either using ultrasonication probe or high-pressure homogenization and optimized using 2</span><sup style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">2</sup><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">-star factorial design by analyzing the effect of NLC composition on their physicochemical parameters. These NLC were optimized using a design of experiments approach and were characterized using different physicochemical techniques. Moreover, short-term stability and cell viability using HaCat cells were assessed. Antimicrobial efficacy of the developed NLC was assessed in vitro and ex vivo.</span><strong style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">Results:</strong><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> NLC encapsulating thymol were developed and optimized and demonstrated a prolonged thymol release. The formulation was dispersed in gels and a screening of several gels was carried out by studying their rheological properties and their skin retention abilities. From them, carbomer demonstrated the capacity to be highly retained in skin tissues, specifically in the epidermis and dermis layers. Moreover, antimicrobial assays against healthy and pathological skin pathogens demonstrated the therapeutic efficacy of thymol-loaded NLC gelling systems since NLC are more efficient in slowly reducing </span><em style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">C. acnes</em><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> viability, but they possess lower antimicrobial activity against </span><em style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">S. epidermidis</em><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">, compared to free thymol.</span><strong style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">Conclusion:</strong><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> Thymol was successfully loaded into NLC and dispersed in gelling systems, demonstrating that it is a suitable candidate for topical administration against acne vulgaris by eradicating pathogenic bacteria while preserving the healthy skin microbiome.</span></p> |
| publishDate |
2024 |
| dc.date.none.fl_str_mv |
2024 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/2445/207864 |
| url |
https://hdl.handle.net/2445/207864 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Reproducció del document publicat a: https://doi.org/10.2147/IJN.S433686 International Journal of Nanomedicine, 2024, vol. 19, p. 1225-1248 https://doi.org/10.2147/IJN.S433686 |
| dc.rights.none.fl_str_mv |
cc-by-nc (c) Folle C. et al., 2024 http://creativecommons.org/licenses/by-nc/4.0/ info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
cc-by-nc (c) Folle C. et al., 2024 http://creativecommons.org/licenses/by-nc/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Dove Medical Press |
| publisher.none.fl_str_mv |
Dove Medical Press |
| dc.source.none.fl_str_mv |
Articles publicats en revistes (Biologia, Sanitat i Medi Ambient) reponame:Dipòsit Digital de la UB instname:Universidad de Barcelona |
| instname_str |
Universidad de Barcelona |
| reponame_str |
Dipòsit Digital de la UB |
| collection |
Dipòsit Digital de la UB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869403035250196480 |
| spelling |
Gel-Dispersed Nanostructures Lipid Carriers Loading Thymol Designed for Dermal PathologiesCarvajal Vidal, Paulina AndreaFolle, CamilaMarqués Villavecchia, Ana M.Díaz-Garrido, NataliaSánchez-López, E. (Elena) Suñer Carbó, J. (Joaquim)Halbaut, LydaMallandrich Miret, MireiaEspina García, MartaBadía Palacín, JosefaBaldomà Llavinés, LauraGarcía López, María LuisaCalpena Campmany, Ana CristinaGels (Farmàcia)Emulsions (Farmàcia)NanopartículesGels (Pharmacy)Emulsions (Pharmacy)Nanoparticles<p><strong style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">Purpose:</strong><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> </span><em style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">Acne vulgaris</em><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> is one of the most prevalent dermal disorders affecting skin health and appearance. To date, there is no effective cure for this pathology, and the majority of marketed formulations eliminate both healthy and pathological microbiota. Therefore, hereby we propose the encapsulation of an antimicrobial natural compound (thymol) loaded into lipid nanostructured systems to be topically used against acne.</span><strong style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">Methods:</strong><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> To address this issue, nanostructured lipid carriers (NLC) capable of encapsulating thymol, a natural compound used for the treatment of acne vulgaris, were developed either using ultrasonication probe or high-pressure homogenization and optimized using 2</span><sup style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">2</sup><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">-star factorial design by analyzing the effect of NLC composition on their physicochemical parameters. These NLC were optimized using a design of experiments approach and were characterized using different physicochemical techniques. Moreover, short-term stability and cell viability using HaCat cells were assessed. Antimicrobial efficacy of the developed NLC was assessed in vitro and ex vivo.</span><strong style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">Results:</strong><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> NLC encapsulating thymol were developed and optimized and demonstrated a prolonged thymol release. The formulation was dispersed in gels and a screening of several gels was carried out by studying their rheological properties and their skin retention abilities. From them, carbomer demonstrated the capacity to be highly retained in skin tissues, specifically in the epidermis and dermis layers. Moreover, antimicrobial assays against healthy and pathological skin pathogens demonstrated the therapeutic efficacy of thymol-loaded NLC gelling systems since NLC are more efficient in slowly reducing </span><em style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">C. acnes</em><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> viability, but they possess lower antimicrobial activity against </span><em style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">S. epidermidis</em><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">, compared to free thymol.</span><strong style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )">Conclusion:</strong><span style="background-color:rgb( 255 , 255 , 255 );color:rgb( 85 , 85 , 85 )"> Thymol was successfully loaded into NLC and dispersed in gelling systems, demonstrating that it is a suitable candidate for topical administration against acne vulgaris by eradicating pathogenic bacteria while preserving the healthy skin microbiome.</span></p>Dove Medical Press2024info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/207864Articles publicats en revistes (Biologia, Sanitat i Medi Ambient)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésReproducció del document publicat a: https://doi.org/10.2147/IJN.S433686International Journal of Nanomedicine, 2024, vol. 19, p. 1225-1248https://doi.org/10.2147/IJN.S433686cc-by-nc (c) Folle C. et al., 2024http://creativecommons.org/licenses/by-nc/4.0/info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/2078642026-05-27T06:46:51Z |
| score |
15,300719 |